BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31899212)

  • 41. The toxicology of hydroquinone--relevance to occupational and environmental exposure.
    DeCaprio AP
    Crit Rev Toxicol; 1999 May; 29(3):283-330. PubMed ID: 10379810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A case-control study to investigate the risk of leukaemia associated with exposure to benzene in petroleum marketing and distribution workers in the United Kingdom.
    Rushton L; Romaniuk H
    Occup Environ Med; 1997 Mar; 54(3):152-66. PubMed ID: 9155776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of potential pathways and microRNA-mRNA networks associated with benzene metabolite hydroquinone-induced hematotoxicity in human leukemia K562 cells.
    Yu CH; Yang SQ; Li L; Xin Y; Zhang F; Liu XF; Yi ZC
    BMC Pharmacol Toxicol; 2022 Apr; 23(1):20. PubMed ID: 35366954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell lines.
    Sandhu R; Rivenbark AG; Coleman WB
    Int J Oncol; 2012 Aug; 41(2):721-32. PubMed ID: 22664488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leukaemia-specific chromosome damage detected by comet with fluorescence in situ hybridization (comet-FISH).
    Escobar PA; Smith MT; Vasishta A; Hubbard AE; Zhang L
    Mutagenesis; 2007 Sep; 22(5):321-7. PubMed ID: 17575318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hydroquinone-induced malignant transformation of TK6 cells by facilitating SIRT1-mediated p53 degradation and up-regulating KRAS.
    Chen Y; Chen J; Yun L; Xu L; Liu J; Xu Y; Yang H; Liang H; Tang H
    Toxicol Lett; 2016 Sep; 259():133-142. PubMed ID: 27515134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reciprocal regulation of chromatin state and architecture by HOTAIRM1 contributes to temporal collinear HOXA gene activation.
    Wang XQ; Dostie J
    Nucleic Acids Res; 2017 Feb; 45(3):1091-1104. PubMed ID: 28180285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kaempferol Modulates DNA Methylation and Downregulates DNMT3B in Bladder Cancer.
    Qiu W; Lin J; Zhu Y; Zhang J; Zeng L; Su M; Tian Y
    Cell Physiol Biochem; 2017; 41(4):1325-1335. PubMed ID: 28278502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia.
    Niederwieser C; Kohlschmidt J; Volinia S; Whitman SP; Metzeler KH; Eisfeld AK; Maharry K; Yan P; Frankhouser D; Becker H; Schwind S; Carroll AJ; Nicolet D; Mendler JH; Curfman JP; Wu YZ; Baer MR; Powell BL; Kolitz JE; Moore JO; Carter TH; Bundschuh R; Larson RA; Stone RM; Mrózek K; Marcucci G; Bloomfield CD
    Leukemia; 2015 Mar; 29(3):567-75. PubMed ID: 25204569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B.
    Itonaga H; Imanishi D; Wong YF; Sato S; Ando K; Sawayama Y; Sasaki D; Tsuruda K; Hasegawa H; Imaizumi Y; Taguchi J; Tsushima H; Yoshida S; Fukushima T; Hata T; Moriuchi Y; Yanagihara K; Miyazaki Y
    Leukemia; 2014 Jul; 28(7):1459-66. PubMed ID: 24457336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prostaglandin E
    Wong CC; Kang W; Xu J; Qian Y; Luk STY; Chen H; Li W; Zhao L; Zhang X; Chiu PW; Ng EK; Yu J
    Theranostics; 2019; 9(21):6256-6268. PubMed ID: 31534549
    [No Abstract]   [Full Text] [Related]  

  • 52. Induction of granulocytic differentiation in myeloblasts by hydroquinone, a metabolite of benzene, involves the leukotriene D4 receptor.
    Hazel BA; Kalf GF
    Recept Signal Transduct; 1996; 6(1):1-12. PubMed ID: 8933618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes in DNA methylation patterns in subjects exposed to low-dose benzene.
    Bollati V; Baccarelli A; Hou L; Bonzini M; Fustinoni S; Cavallo D; Byun HM; Jiang J; Marinelli B; Pesatori AC; Bertazzi PA; Yang AS
    Cancer Res; 2007 Feb; 67(3):876-80. PubMed ID: 17283117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hydroquinone-induced FOXP3-ADAM17-Lyn-Akt-p21 signaling axis promotes malignant progression of human leukemia U937 cells.
    Chen YJ; Liu WH; Chang LS
    Arch Toxicol; 2017 Feb; 91(2):983-997. PubMed ID: 27307158
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of mir-92a-3p on hydroquinone induced changes in human lymphoblastoid cell cycle and apoptosis.
    Xuan M; Wu Y; Wang H; Ye Z; Wu H; Chen Y; Yang H; Tang H
    Environ Toxicol; 2023 Jun; 38(6):1420-1430. PubMed ID: 36988267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-7-5p targeted Rb regulating cell cycle is involved in hydroquinone-induced malignant progression in human lymphoblastoid TK6 cells.
    Zhai L; Gao Y; Cui Z; Chen L; Yu L; Guo P; Zhu D; Tang H; Liu X; Luo H
    Food Chem Toxicol; 2023 Dec; 182():114186. PubMed ID: 37951342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of centrosome amplification by formaldehyde, but not hydroquinone, in human lymphoblastoid TK6 cells.
    Ji Z; McHale CM; Bersonda J; Tung J; Smith MT; Zhang L
    Environ Mol Mutagen; 2015 Jul; 56(6):535-44. PubMed ID: 25821186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The benzene metabolites hydroquinone and catechol act in synergy to induce dose-dependent hypoploidy and -5q31 in a human cell line.
    Stillman WS; Varella-Garcia M; Irons RD
    Leuk Lymphoma; 1999 Oct; 35(3-4):269-81. PubMed ID: 10706450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of Dnmt3b accelerates MLL-AF9 leukemia progression.
    Zheng Y; Zhang H; Wang Y; Li X; Lu P; Dong F; Pang Y; Ma S; Cheng H; Hao S; Tang F; Yuan W; Zhang X; Cheng T
    Leukemia; 2016 Dec; 30(12):2373-2384. PubMed ID: 27133822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer.
    Huidobro C; Urdinguio RG; Rodríguez RM; Mangas C; Calvanese V; Martínez-Camblor P; Ferrero C; Parra-Blanco A; Rodrigo L; Obaya AJ; Suárez-Fernández L; Astudillo A; Hernando H; Ballestar E; Fernández AF; Fraga MF
    Eur J Cancer; 2012 Sep; 48(14):2270-81. PubMed ID: 22244828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.